SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up -- Ignore unavailable to you. Want to Upgrade?


To: K.Martin who wrote (931)7/3/1998 4:48:00 PM
From: Maurice S. Green  Respond to of 1055
 
All---I am a seeded survivor and can say that the proceedure did
nothing to interfere with my life style. Played golf 24 hours later.
Those who had surgery certainly can not say the same.Not to say
that seeding is right for everyone, but given the choice , the
choice by the patient is obvious.

The fear of oversupply, probably does not take into account the
increase in doctors knowledgeable in the proceedure. I know my
doctor is teaching many others regularly. If I remember correctly,
in Sept. '97 he had to delay my proceedure because of a shortage
of seeds.

Regardless of this, the market will do what it will do.




To: K.Martin who wrote (931)7/3/1998 4:51:00 PM
From: dfloydr  Read Replies (1) | Respond to of 1055
 
<< an article in June 1998 edition of Urology, comes out in favor of radical prostatectomy over using Iodine seeds on the basis of seven-year disease free rates>>

I just heard from brother Dale:

Urology magazine article reported to favor surgery over seeding. Dale just told me that he found the article in the hospital library this morning while doing rounds. It is a retrospective study .... that means researchers now going back over old records to see what they can find from histories. The report is done by Johns Hopkins. It is NOT randomized. The surgery data is from Johns Hopkins records, where they do thousands of these surgeries and do them well. (Not all surgeons are that good). The seed data is from U. of Washington, where Dale learnt seeding. It reports 90% success rates after seven years for radical prostatectomy and 78% for seeds. Note that the two data bases were not compiled by the same systems.

There are two editorial comments that say: This is very interesting and further, randomized study should be done to see whether this is in general true or whether other factors have affected these results. For example, Johns Hopkins surgeons are especially good and results at other locations may not be as good. Which age groups are patients in? Or what is the definition of success? No more cancer? OK, but how about side effects?